7 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Episodic Migraine #EBM ... Erenumab #Migraine #CGRP ... VisualAbstract #NEJM
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
NEJMsa065779 #Policy #EBM ... Publication #Bias #Comparison ... #FDA #NEJM
â–º
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... Fremanezumab #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Intravascular Complications of Central Venous Catheterization by Insertion Site
Complications in the Three-Choice Comparison, According to Insertion-Site
the Three-Choice Comparison ... #EBM #RCT #Central ... Infections #Selection #NEJM
Selective Publication of Antidepressant Trials

A more complete picture: contrasting the journal version of antidepressant trials with
NEJMsa065779 #Policy #EBM ... Publication #Bias #Comparison ... #FDA #NEJM